UPDATE 1-NORDIC STOCKS - Factors to watch on July 13
2009-07-13 02:27:00.0
Track China's Leaders
Wed, Aug 12 2009
Wed, Aug 12 2009
Tue, Aug 11 2009
Mon, Jul 13 2009
Mon, Jul 13 2009
Mon  EDT
(Adds Novo Nordisk, Norske Skog, Getinge)
HELSINKI, July 13
The Swedish telecom equipment maker Ericsson will invest in a new research and development centre in South Korea and increase its staff to about 1,000, the South Korean presidential office said at the weekend.
"According to the plan, Ericsson is expected to invest approximately $1.5 billion in South Korea in the next five years," the presidential Blue House said in a statement.
For more on the company, double click [ERICb.ST]
The Norwegian company said it was selling its 56 percent stake in newsprint mill in Shanghai, booking a 255 million Norwegian crown ($38.95 million) loss, as its restructured its operations in China.
For more on the company, double click [NSG.OL]
The Swedish savings bank foundations, Sparbanksstiftelserna, are demanding compensation from Folksam, Erste Bank (
) and the Swedish Export Credit Corporation (SEK) related to the transfer of Swedbank shares earlier this year, Swedish business daily Dagens Industri reported at the weekend.
Folksam, Erste Bank and SEK took over Swedbank shares put up as collateral for a loan from the foundations in early March.
In the days following the announcement, but before shares were transferred, the Swedbank stock rose roughly 35 percent. The rise in the stock had not been reflected in the transfer of the shares, the foundations said.
"We have issued a demand to our lenders," Lorentz Andersson, chairman of the foundations management firm, was quoted as saying. "This concerns several hundred million crowns."
For more on the company, double click [SWEDa.ST]
For more on the company, double click [GETIb.ST]
Swedish officials are investigating whether Danish pharmaceuticals group Novo Nordisk broke rules by hosting nearly 200 Swedish doctors and nurses on a trip to South Africa in 2006, daily Berlingske Tidende said. "As a patient, you should be able to trust that your doctor is objective and not influenced by some drug company," Swedish state prosecutor Nils-Erik Schultz said, according to the newspaper. The company told a Swedish daily it was cooperating 100 percent with the investigation, Berlingske Tidende said.
For more on the company, double click on [NOVOb.CO]
** For a summary of upcoming results and forecasts, double click on [NORD/EQTY]
** For the western European company diary covering earnings, shareholder meetings, news conferences and analysts' meetings, click on [WEU/EQUITY] or type in the code and hit the f9 button.
** Double click on <0#.INDEX.ST> for Swedish indices, <0#.INDEX.CO> for Danish indices, <0#.INDEX.HE> for Finnish indices and <0#.INDEX.OL> for Norwegian indices
** For Nordic top news items, double click on [TOP/NORD]
(Additional reporting by Copenhagen, Oslo and Stockholm newsrooms) (Helsinki Newsroom; +358-9-6805-0244) ($1=6.546 Norwegian Crown) ($1=7.969 Swedish Crown)
